COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,785 Articles (22,523 medRxiv, 8,262 bioRxiv)

Most recent first Previous |  Page 945: Articles 9441-9450  | Next

Multisystemic inflammatory syndrome following COVID-19 mRNA vaccine in children: a national post-authorization pharmacovigilance study
Ouldali, N., Bagheri, H., Salvo, F., Antona, D., Pariente, A., Leblanc, C., Tebacher, M., Micallef, J., Levy, C., Cohen, R., Javouhey, E., Bader-Meunier, B., Ovaert, C., Renolleau, S., Hengten, V., Kone-Paut, I., Deschamps, N., De Pontual, L., Iriart, X., Gras-Le Guen, C., Angoulvant, F., Belot, A.
10.1101/2022.01.17.22269263 — Posted: 2022-01-18 Discussion: Onsite
Attitudes towards vaccines, intent to vaccinate and the relationship with COVID-19 vaccination rates in individuals with schizophrenia
Raffard, S.
10.1101/2022.01.12.22269167 — Posted: 2022-01-17
Phylodynamic analysis of SARS-CoV-2 spread in Rio de Janeiro, Brazil, highlights how metropolitan areas act as dispersal hubs for new variants.
Lamarca, A. P., Almeida, L. G. P. d., Francisco Junior, R. d. S., Cavalcante, L., Brustolini, O., Gerber, A. L., Guimaraes, A. P. d. C., Oliveira, T. H. d., Nascimento, E. R. d. S., Policarpo, C., Souza, I. V. d., Carvalho, E. M. d., Ribeiro, M. S., Carvalho, S., Silva, F. D. d., Garcia, M. H. d. O., Souza, L. M. d., Silva, C. G. d., Ribeiro, C. L. P., Cavalcanti, A. C., Mello, C. M. B. d., Tanuri, A., Vasconcelos, A. T. R.
10.1101/2022.01.17.22269136 — Posted: 2022-01-17
EFCAB4B (CRACR2A) genetic variants associated with COVID-19 fatality
Wang, D., Wiktor, S. D., Cheng, C. W., Simmons, K. J., Money, A., Pedicini, L., Carlton, A., Breeze, A. L., McKeown, L.
10.1101/2022.01.17.22269412 — Posted: 2022-01-17
Development and validation of the Symptom Burden Questionnaire™ for Long COVID: a Rasch analysis
Hughes, S. E., Haroon, S., Subramanian, A., McMullan, C., Aiyegbusi, O. L., Turner, G. M., Jackson, L., Davies, E. H., Frost, C., McNamara, G., Price, G., Matthews, K., Camaradou, J., Ormerod, J., Walker, A., Calvert, M. J.
10.1101/2022.01.16.22269146 — Posted: 2022-01-17
Real-world monitoring of BNT162b2 vaccine-induced SARS-CoV-2 B and T cell immunity in naive healthcare workers: a prospective single center study
Calcoen, B., Callebaut, K., Vandenbulcke, A., Callewaert, N., Bossuyt, X., Van Weyenbergh, J., Maes, P., Imbrechts, M., Vercruysse, T., Thibaut, H. J., Zapf, D., Dieckmann, K., Vanhoorelbeke, K., Geukens, N., De Meyer, S., Maes, W.
10.1101/2022.01.17.22269081 — Posted: 2022-01-17
Limited cross-variant immunity after infection with the SARS-CoV-2 Omicron variant without vaccination
Suryawanshi, R. K., Chen, I. P., Ma, T., Syed, A. M., Simoneau, C. R., Ciling, A., Khalid, M. M., Sreekumar, B., Chen, P.-Y., George, A. F., Kumar, G. R., Montano, M., Garcia-Knight, M. A., Brazer, N., Saldhi, P., Sotomayor-Gonzalez, A., Servellita, V., Gliwa, A., Nguyen, J., Silva, I., Milbes, B., Kojima, N., Hess, V., Shacreaw, M., Lopez, L., Brobeck, M., Turner, F., Soveg, F. W., Fang, X., Maishan, M., Matthay, M., Morris, M. K., Wadford, D., Hanson, C., Greene, W. C., Andino, R., Spraggon, L., Roan, N. R., Chiu, C. Y., Doudna, J., Ott, M.
10.1101/2022.01.13.22269243 — Posted: 2022-01-17 Discussion: Onsite | Offsite
Tuftsin: a natural molecule against SARS-CoV-2 infection
Huang, J., Wang, J., Wang, Z., Chu, M., Wang, Y.
10.1101/2022.01.10.475746 — Posted: 2022-01-17
Increased airborne transmission of COVID-19 with new variants. Implications for health policies.
Rowe, B. R., Canosa, A., Meslem, A., Rowe, F.
10.1101/2022.01.13.22269234 — Posted: 2022-01-17
Sero-Prevalence of Covid-19 among workers in Malaysia
Noordin, N. M., Omar, A., Isharudin, I. H., Idris, R., Chem, Y., Mat Sahat, I. S., Sengol, S., Aziz, Z. A., Lim, Z. z., Lim, T. O.
10.1101/2022.01.16.22269388 — Posted: 2022-01-17

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).